Pattern Computer Initiates Preclinical Study to Evaluate the Effectiveness of Potential Drug Combinations Against High-Grade Serous Ovarian Cancer
REDMOND, WA, APRIL 18, 2022 -- Pattern ComputerĀ®, Inc. (PCI) is thrilled to announce that our combination drug candidates targeting High-grade Serous Ovarian Cancer (HGSOC) have moved into a preclinical in vitro study. The goal is to evaluate the effectiveness [...]